• Asia’s Longest Running Generics Event
  •  Venturing into R&D & Partnerships
  •   Innovative Models for Sustainable Growth in Asia

The past decade has witnessed significant growth and stern competition amongst generic pharmaceutical companies. This trend is likely to continue with tightened regulations and a patent cliff in the years ahead. IBC’s Generics 2014 is into its 9th year with a new agenda to unlock key concerns through interactive sessions. The conference is a perfect opportunity to gain critical insights on strategic partnerships, marketing planning, investment opportunities in supergenerics, biosimilar challenges, innovative technology and streamlined manufacturing best practices from MNC and regional generics companies.

What’s NEW for 2014?

  • Reinventing the generics business and new areas of growth
  • Sales force effectiveness and innovative channels for generics distribution
  • Establishing sustainable relationships with internal and external stakeholders
  • Special focus on biosimilars and supergenerics
  • Successful Quality by Design (QbD) and Cost Reduction strategies

To see full agenda, click here »

Featured Speakers Include

Krishna Prasad
Associate Director Regulatory Affairs
Actavis, Singapore
Sreeraj Roy
Business Director
Pfizer, Indonesia
Allan Marx Ancheta
Director Business Development and Strategy, Commercial Innovation and Alliance
Merck, Philippines
Philip Cox
Country Manager
PT Takeda Indonesia, Indonesia
Dr. Shirish Kulkarni
Senior Vice President, Formulation Development
Sun Pharmaceutical Industries Ltd., India

To see full speaker line-up, click here »

Produced bySession Spotlight Sponsor  


Media Partners   

International Marketing Partner